BrianGregorySalisburyMD

PubMed

• 7 citations
  Effect of mometasone furoate (MF)/formoterol fumarate (F) combination (MF/F) on late-phase responses in allergen-challenged Brown Norway rats.
  Richard W. Chapman, Aidan K. Curran, Aileen House, Jennifer Richard, Brian Salisbury, John C. Hunter, John C. Anthes, Jonathan E. Phillips> ;Pulmonary Pharmacology & Therapeutics. 2011 Feb 1
• 5 citations
  Alpha-2c-adrenergic receptors contribute to basal nasal patency in the anesthetized cat.
  Garfield G. Mingo, Michel R. Corboz, Brian G. Salisbury, Mccormick Kevin D, Christopher W. Boyce, Gitali Mukhopadhyay, Robbie L. McLeod> ;Pharmacology. 2010 Jan 1
• Inducible expression and pharmacological characterization of the mouse metabotropic glutamate 5b receptor
  Brian G. Salisbury, Gitali Mukhopadhyay, Mitch Kostich, Thomas M. Laz, Ellie D. Norris> ;European Journal of Pharmacology. 2008 Jan 28
• 19 citations
  Activation of central melanocortin receptors by MT-II increases cavernosal pressure in rabbits by the neuronal release of NO.
  Rao Vemulapalli, Stan Kurowski, Brian G. Salisbury, Eric M. Parker, Harry R. Davis> ;British Journal of Pharmacology. 2001 Dec 1
• 68 citations
  [D-Trp34] neuropeptide Y is a potent and selective neuropeptide Y Y5 receptor agonist with dramatic effects on food intake☆
  Eric M. Parker, Ambikaipakan Balasubramaniam, Mario Guzzi, Deborra E Mullins, Brian G. Salisbury, Sulaiman Sheriff, Melanie B. Witten, Joyce J. Hwa> ;Peptides. 2000 Mar 1
• 76 citations
  Activation of the NPY Y5 receptor regulates both feeding and energy expenditure.
  Joyce J. Hwa, Melanie B. Witten, P. Williams, Lorraine Ghibaudi, Jun Gao, Brian G. Salisbury, Deborra E Mullins, Fozia Hamud, Catherine D. Strader, Eric M. Parker> ;The American Journal of Physiology. 1999 Nov 1
• 96 citations
  GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists
  Eric M. Parker, Carol K Babij, Ambikaipakan Balasubramaniam, Robert E. Burrier, Mario Guzzi, Fozia Hamud, Gitali Mukhopadhyay, Mark Stephen Rudinski, Z. Tao, Melissa A...> ;European Journal of Pharmacology. 1998 May 15
• 59 citations
  2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus.
  John W. Clader, Duane A. Burnett, Mary Ann Caplen, Martin S. Domalski, Sundeep Dugar, Wayne D. Vaccaro, Rosy Sher, Margaret E Browne, Hongrong Zhao, Robert E. Burrier,...> ;Journal of Medicinal Chemistry. 1996 Sep 13
• 27 citations
  Inhibitors of acyl CoA:cholesterol acyltransferase.
  Wayne D. Vaccaro, Cindy Amore, Joel G. Berger, Robert E. Burrier, John W. Clader, Harry R. Davis, Martin S. Domalski, Tom Fevig, Brian G. Salisbury, Rosy Sher> ;Journal of Medicinal Chemistry. 1996 Apr 12
• 2 citations
  Amides of piperidine, morpholine and piperazine substituted 1-phenylethylamines: inhibitors of acylCoA:cholesterol acyltransferase (ACAT) activity in vitro and in vivo.
  Sundeep Dugar, Harry R. Davis, Robert E. Burrier, Brian G. Salisbury> ;Bioorganic & Medicinal Chemistry. 1995 Sep 1
• 14 citations
  Substituted (1,2-diarylethyl)amide acyl-CoA:cholesterol acyltransferase inhibitors : effect of polar groups on in vitro and in vivo activity
  John W. Clader, Joel G. Berger, Robert E. Burrier, Harry R. Davis, Martin S. Domalski, Dugar Sundeep, Timothy Kogan, Brian G. Salisbury, Wayne Vaccaro> ;Journal of Medicinal Chemistry. 1995 May 12
• 73 citations
  Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461
  Brian G. Salisbury, Harry R. Davis, Robert E. Burrier, Duane A. Burnett, George Boykow, Mary Ann Caplen, Anthony Clemmons, Douglas S Compton, Lizbeth M. Hoos, Daniel G...> ;Atherosclerosis. 1995 May 1
• Join now to see all